| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8769863 | American Journal of Kidney Diseases | 2018 | 9 Pages |
Abstract
Uric acid concentration is an independent risk factor for kidney failure in earlier stages of CKD and has a J-shaped relationship with all-cause mortality in CKD. Adequately powered randomized placebo-controlled trials in CKD are needed to test whether urate lowering may prove to be an effective approach to prevent complications and progression of CKD.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Nephrology
Authors
Anand Srivastava, Arnaud D. Kaze, Ciaran J. McMullan, Tamara Isakova, Sushrut S. Waikar,